Rockwell Medical (RMTI) Receivables (2010 - 2026)

Rockwell Medical (RMTI) has reported Receivables for 17 consecutive years, with $8.3 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Receivables rose 2.73% year-over-year to $8.3 million; the trailing twelve-month figure through Jun 2026 stood at $8.3 million (up 2.73% YoY), and the FY2025 full-year result was $8.1 million, down 1.79% from the prior year.
• Receivables eased to $8.3 million in Q2 2026 per RMTI's latest filing, from $8.8 million in the prior quarter.
• Across five years, Receivables topped out at $16.2 million in Q2 2022 and bottomed at $5.4 million in Q2 2023.
• Historically, Receivables has averaged $10.0 million across 5 years, with a median of $9.1 million in 2023.
• The sharpest annual moves came in 2023 and 2024: Receivables plunged 66.56% in 2023, then soared 100.33% in 2024.
• Over 5 years, Receivables stood at $12.5 million in 2022, then decreased by 12.92% to $10.9 million in 2023, then retreated by 23.94% to $8.3 million in 2024, then dropped by 1.79% to $8.1 million in 2025, then climbed by 1.99% to $8.3 million in 2026.
• According to Business Quant data, Receivables over the past three periods registered $8.3 million, $8.8 million, and $8.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.